AU
UK
CA
NZ
IND
US
Index Update:MongoDB soared nearly 30% and Okta rose about 6% in extended trading after strong earnings fueled by AI-driven demand, while Cracker Barrel jumped over 7% after reversing a controversial logo change. Earlier, U.S. stocks closed higher, with the Dow, S&P 500, and Nasdaq …
Domo (NASDAQ: DOMO), an AI and data products company, announced a set of enhancements to its existing integration with Google Cloud’s BigQuery aimed at improving governance, user experience, and multi-user collaboration for joint customers. The updates focus on administration controls, clearer configuration workflows, and …
MongoDB, Inc. (NASDAQ: MDB) reported results for the second quarter ended July 31, 2025, with revenue expansion led by subscription sales and continued margin improvement on a non-GAAP basis. Total revenue for the quarter was $591.4 million, up 24% from the comparable period a …
MicroCloud Hologram Inc. (NASDAQ: HOLO) said it expects a material year-over-year turnaround to profitability for the first half of 2025, projecting net profit in excess of RMB 230 million versus a reported net loss of roughly RMB 120 million in the same period last …
Immuron Limited (ASX: IMC; NASDAQ: IMRN) has entered a strategic partnership with InvestorHub, a direct-to-investor engagement software provider, as part of a broader effort to streamline communications with shareholders and the investment community. The agreement establishes an interactive investor hub designed to consolidate corporate …
Index Update:On Monday, the Dow fell 0.77%, the S&P 500 dropped 0.43%, and the Nasdaq slipped 0.22%, with nine of 11 S&P sectors lower, led by consumer staples, healthcare, and utilities. Losses followed profit-taking after Friday’s rally on Fed rate-cut signals, while Interactive Brokers …
EHang reported a sharp quarter of topline growth and operational milestones as it pushes commercialisation of its EH216 series. The company posted Q2 2025 revenue of RMB147.2 million (US$20.5 million), a 44.2% increase year-over-year and a 464.0% jump quarter-over-quarter, and reported a gross margin …
Evoke Pharma announced a set of distribution agreements intended to materially broaden patient access to GIMOTI® nasal spray, the only FDA-approved intranasal treatment for adults with acute and recurrent diabetic gastroparesis. The company said strategic arrangements with Omnicell (NASDAQ: OMCL) and Brentwood Pharmacy will …
Please wait processing your request...